MARSHALL WACE, LLP - CLARUS THERAPEUTICS HLDNGS I ownership

Back to all holdings Add to watchlist

CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L115. A total of 5 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CLARUS THERAPEUTICS HLDNGS I
ValueSharesWeighting
Q2 2022$24,000
-93.6%
63,063
-74.8%
0.00%
-100.0%
Q1 2022$373,000
-38.7%
250,0000.0%0.00%0.0%
Q4 2021$608,000
+18.1%
250,000
+158.8%
0.00%
-50.0%
Q3 2021$515,000–96,600–0.00%–
 Download
Other shareholders

There were no reported owners of CLARUS THERAPEUTICS HLDNGS I in Q3 2022.

NameSharesValueWeighting ↓
View complete list of CLARUS THERAPEUTICS HLDNGS I shareholders